Why Revenue Cycle Management Systems Fall Behind—and How to Modernize Them
Clinical lab billing teams face an overwhelming number of challenges if revenue cycle strategies fall short
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Clinical lab billing teams face an overwhelming number of challenges if revenue cycle strategies fall short
As of March 1, 2026, CMS will move CLIA away from paper-based transactions to improve efficiency and payments
The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services
A lawyer advises medical laboratories on how to improve their avenues for reporting unethical behavior
A leaked budget document for the next fiscal year suggested non-user fee funding may be up slightly compared to recent years.
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes
Judge rules that the FDA has ‘no authority’ to issue its rule governing laboratory-developed tests
Put into place late last year, the new rules place more emphasis on formal and continuing education requirements
Other recent legal actions include a self-disclosure settlement and punishment for alleged improper diagnostic test add-ons